Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Anesthesiology
|
September 20, 2017
A Primer for Diagnosing and Managing Malignant Hyperthermia Susceptibility
Marilyn Green Larach
Anesthesia and Analgesia
|
September 4, 2019
Dantrolene Should Be Readily Available Wherever Malignant Hyperthermia Triggering Drugs Are Stocked
Marilyn Green Larach, Sheila Riazi, Henry Rosenberg
Anesthesiology
|
January 14, 2025
Volatile Anesthetic Intensive Care Unit Sedation: Comment
Henry Rosenberg, Charles Watson, Marilyn Green Larach
Anesthesiology
|
March 24, 2011
Anesthesiologists as genetic counselors?
Henry Rosenberg, Georgirene D Vladutiu, Marilyn Green Larach
Anesthesiology
|
May 24, 2012
Confirmation of nonanesthetic-induced malignant hyperthermia
Marilyn Green Larach, Gregory C Allen, Henry Rosenberg
Neurocritical Care
|
February 28, 2009
A life worth living: seven years after craniectomy
David R Larach, Daniel B Larach, Marilyn Green Larach
Anesthesia and Analgesia
|
March 5, 2011
Complications associated with the administration of dantrolene 1987 to 2006: a report from the North American Malignant Hyperthermia Registry of the Malignant Hyperthermia Association of the United States
Barbara W Brandom, Marilyn Green Larach, Min-Shue Alvin Chen, et al.
Anesthesia and Analgesia
|
July 12, 2013
Malignant hyperthermia in Canada: characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands
Sheila Riazi, Marilyn Green Larach, Charles Hu, et al.
Anesthesiology
|
June 13, 2015
Malignant hyperthermia testing in probands without adverse anesthetic reaction
Matthew A Timmins, Henry Rosenberg, Marilyn Green Larach, et al.
Anesthesia and Analgesia
|
January 19, 2010
Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006
Marilyn Green Larach, Gerald A Gronert, Gregory C Allen, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Anesthesiology
|
September 20, 2017
A Primer for Diagnosing and Managing Malignant Hyperthermia Susceptibility
Marilyn Green Larach
Anesthesia and Analgesia
|
September 4, 2019
Dantrolene Should Be Readily Available Wherever Malignant Hyperthermia Triggering Drugs Are Stocked
Marilyn Green Larach, Sheila Riazi, Henry Rosenberg
Anesthesiology
|
January 14, 2025
Volatile Anesthetic Intensive Care Unit Sedation: Comment
Henry Rosenberg, Charles Watson, Marilyn Green Larach
Anesthesiology
|
March 24, 2011
Anesthesiologists as genetic counselors?
Henry Rosenberg, Georgirene D Vladutiu, Marilyn Green Larach
Anesthesiology
|
May 24, 2012
Confirmation of nonanesthetic-induced malignant hyperthermia
Marilyn Green Larach, Gregory C Allen, Henry Rosenberg
Neurocritical Care
|
February 28, 2009
A life worth living: seven years after craniectomy
David R Larach, Daniel B Larach, Marilyn Green Larach
Anesthesia and Analgesia
|
March 5, 2011
Complications associated with the administration of dantrolene 1987 to 2006: a report from the North American Malignant Hyperthermia Registry of the Malignant Hyperthermia Association of the United States
Barbara W Brandom, Marilyn Green Larach, Min-Shue Alvin Chen, et al.
Anesthesia and Analgesia
|
July 12, 2013
Malignant hyperthermia in Canada: characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands
Sheila Riazi, Marilyn Green Larach, Charles Hu, et al.
Anesthesiology
|
June 13, 2015
Malignant hyperthermia testing in probands without adverse anesthetic reaction
Matthew A Timmins, Henry Rosenberg, Marilyn Green Larach, et al.
Anesthesia and Analgesia
|
January 19, 2010
Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006
Marilyn Green Larach, Gerald A Gronert, Gregory C Allen, et al.
Page
of 2